← FDA DRUG APPROVALS

FDA ANDA · ANDA078161

FINASTERIDE

Sponsor: NATCO PHARMA

APPLICATION
ANDA078161
TYPE
ANDA
ORIGINAL APPROVAL
2013-11-05
LATEST ACTION
2023-08-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FINASTERIDEDiscontinued
FINASTERIDE 1MG · TABLET · ORAL

Approval history

2023-08-08Labeling · Supplement 6 · standardAP
2023-08-08Labeling · Supplement 7 · standardAP
2015-09-02Labeling · Supplement 2 · standardAP
2013-11-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →